AgenusvsJohnson & Johnson

AGEN and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

AGEN

Agenus Inc.

$6.17

Value $386M

+0.47%
AGEN's page

Agenus (AGEN) has a market value of $386M and Johnson & Johnson (JNJ) $654B. Over the last year, with dividends, AGEN moved +46.9% and JNJ +36.9%. The P/E is 13.1 for AGEN and 40.6 for JNJ. Dividend yield: AGEN none, JNJ 1.95%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AGEN$386M

    JNJ$654B

    JNJ is 1,692 times AGEN

  • Revenue, 12 months

    AGEN$134M

    JNJ$99.3B

    JNJ is 742 times AGEN

  • Net income, 12 months

    AGEN$29M

    JNJ$16.1B

    JNJ is 546 times AGEN

  • Operating margin

    AGEN38.9%

    JNJ–

  • ROIC

    AGEN–

    JNJ12.4%

  • P/E

    AGEN13.1

    JNJ40.6

    JNJ is 3.1 times AGEN

  • Dividend yield

    AGEN0.0%

    JNJ2.0%

    2.0 points apart

  • 5-year return

    AGEN-90.8%

    JNJ+91.4%

    182.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AGEN-90.8%

JNJ+91.4%

010020020222023202420252026
Returns by period
PeriodAGENWith dividendsJNJWith dividends
1 year since November 19, 2025+46.9%Price +46.9%+36.9%Price +33.9%
3 years since November 20, 2023-58.3%-25.3% a yearPrice -58.3%+95.5%+25.0% a yearPrice +80.9%
5 years since November 19, 2021-90.8%-38.0% a yearPrice -90.8%+91.4%+13.9% a yearPrice +66.5%
10 years since November 21, 2016-93.5%-23.9% a yearPrice -93.5%+207.3%+11.9% a yearPrice +135.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AGENAgenusJNJJohnson & Johnson

Valuation

AGENJNJ
Valuation
Price$6.17$271.31
Market value$386M$654B
Enterprise value (EV)–$681B
P/E13.140.6
P/E, 5-year median–21.9
P/B–8.0
EV/EBIT–38.4
Free cash flow yield–3.2%

Results and growth

AGENJNJ
Results and growth
Revenue, 12 months$134M$99.3B
Net income, 12 months$29M$16.1B
Free cash flow, 12 months-$104M$20.6B
Earnings per share, 12 months$0.47$6.59
Revenue growth, year on year10.4%6.1%
Revenue growth a year, past+5.3%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

AGENJNJ
Margins and returns on capital
Gross margin100.0%67.6%
Operating margin38.9%–
Net margin22.0%16.2%
ROIC–12.4%
ROE–19.7%

Balance sheet

AGENJNJ
Balance sheet
Cash$87M$17.2B
Total debt–$44.7B
Net debt / EBITDA–1.1
Interest cover0.9×18.0×

Dividends and buybacks

AGENJNJ
Dividends and buybacks
Dividend yield–2.0%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield–0.9%
Shareholder yield–2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AGEN or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Agenus or Johnson & Johnson?

By market value, Johnson & Johnson ($654B) is about 1,691.8 times Agenus ($386M), at today's prices.

How did AGEN and JNJ stock do over the last 10 years?

Since November 21, 2016, AGEN's price moved -93.5% and JNJ's +135.9%. With dividends: AGEN -93.5% (-23.9% a year), JNJ +207.3% (+11.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, AGEN or JNJ?

The dividend yield at today's price is none for Agenus and 1.95% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

What is the P/E of AGEN and JNJ?

At today's price, the P/E is 13.1 for AGEN and 40.6 for JNJ. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Agenus or Johnson & Johnson?

Over the last twelve months, the net margin was 22.0% for Agenus and 16.2% for Johnson & Johnson, and the operating margin 38.9% and –. Revenue was $134M and $99.3B.

Which is the better investment, Agenus or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.